Ethyl 8-fluoro-6-(3-nitrophenyl)-4H-imidazo[1,5-a][1,4]benzodiazepine-3-carboxylate as novel, highly potent, and safe antianxiety agent

被引:36
作者
Anzini, Maurizio [1 ,2 ]
Braile, Carlo [1 ,2 ]
Valenti, Salvatore [1 ,2 ]
Cappelli, Andrea [1 ,2 ]
Vomero, Salvatore [1 ,2 ]
Marinelli, Luciana [3 ]
Limongelli, Vittorio [3 ]
Novellino, Ettore [3 ]
Betti, Laura [4 ]
Giannaccini, Gino [4 ]
Lucacchini, Antonio [4 ]
Ghelardini, Carla [5 ]
Norcini, Monica [5 ]
Makovec, Francesco [7 ]
Giorgi, Gianluca [6 ]
Fryer, R. Ian [8 ]
机构
[1] Univ Siena, Dipartimento Farmaco Chim Tecnol, I-53100 Siena, Italy
[2] Univ Siena, European Res Ctr Drug Discovery & Dev, I-53100 Siena, Italy
[3] Univ Naples Federico II, Dipartimento Chim Farmaceut & Tossicol, I-80131 Naples, Italy
[4] Univ Pisa, Dipartimento Psichiatria Neurobiol Farmacol & Bio, I-56126 Pisa, Italy
[5] Univ Florence, Dipartimento Farmacol Preclin & Clin M Aiazzi Man, I-50139 Florence, Italy
[6] Rottapharm SpA, I-20052 Monza, Italy
[7] Univ Siena, Dipartimento Chim, I-53100 Siena, Italy
[8] Rutgers State Univ, Dept Chem, Newark, NJ 07102 USA
关键词
D O I
10.1021/jm8002944
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Ethyl 8-fluoro-6-(4-nitrophenyl)- and ethyl 8-fluoro-6-(3-nitrophenyl)-4H-imidazo[1,5-a][1,4]benzodiazepine 3-carboxylate 6 and 7 were synthesized as central benzodiazepine receptor (CBR) ligands and tested for their ability to displace [3 H]flumazenil from bovine and human cortical brain membranes. Both compounds showed high affinity for bovine and human CBR. In particular, compound 7 emerged as the most interesting compound, having a partial agonist profile in vitro while possessing useful activity in various animal models of anxiety. In accordance with its partial agonist profile, compound 7 was devoid of typical benzodiazepine, side effects. The homology model of the GABA(A) receptor developed by Cromer et al. was used to assess the binding modes of ligands 6 and 7. From our docking results, the partial agonist activity elicited by compound 7 is likely to be due to the 3'-nitro substituent, which is in the appropriate position to interact with Thr193 of the gamma(2)-subunit by means of a hydrogen bond.
引用
收藏
页码:4730 / 4743
页数:14
相关论文
共 83 条
[1]   PHARMACOLOGICAL PROFILE OF THE IMIDAZOPYRIDINE ZOLPIDEM AT BENZODIAZEPINE RECEPTORS AND ELECTROCORTICOGRAM IN RATS [J].
ARBILLA, S ;
DEPOORTERE, H ;
GEORGE, P ;
LANGER, SZ .
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 1985, 330 (03) :248-251
[2]  
Barnard EA, 1998, PHARMACOL REV, V50, P291
[3]   1,2,3-triazolo[1,5-a]quinoxalines: synthesis and binding to benzodiazepine and adenosine receptors [J].
Bertelli, L ;
Biagi, G ;
Giorgi, I ;
Manera, C ;
Livi, O ;
Scartoni, V ;
Betti, L ;
Giannaccini, G ;
Trincavelli, L ;
Barili, PL .
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 1998, 33 (02) :113-122
[4]   BENZODIAZEPINE RECEPTOR LIGANDS WITH POSITIVE AND NEGATIVE EFFICACY [J].
BRAESTRUP, C ;
NIELSEN, M ;
HONORE, T ;
JENSEN, LH ;
PETERSEN, EN .
NEUROPHARMACOLOGY, 1983, 22 (12B) :1451-1457
[5]  
Braestrup C., 1983, HDB PSYCHOPHARMACOLO, V17, P285
[6]   CHARMM - A PROGRAM FOR MACROMOLECULAR ENERGY, MINIMIZATION, AND DYNAMICS CALCULATIONS [J].
BROOKS, BR ;
BRUCCOLERI, RE ;
OLAFSON, BD ;
STATES, DJ ;
SWAMINATHAN, S ;
KARPLUS, M .
JOURNAL OF COMPUTATIONAL CHEMISTRY, 1983, 4 (02) :187-217
[7]   Mechanism of action of benzodiazepines on GABAA receptors [J].
Campo-Soria, Claudia ;
chang, Yong Chang ;
Weiss, David S. .
BRITISH JOURNAL OF PHARMACOLOGY, 2006, 148 (07) :984-990
[8]   Novel potent and selective central 5-HT3 receptor ligands provided with different intrinsic efficacy.: 2.: Molecular basis of the intrinsic efficacy of arylpiperazine derivatives at the central 5-HT3 receptors [J].
Cappelli, A ;
Anzini, M ;
Vomero, S ;
Canullo, L ;
Mennuni, L ;
Makovec, F ;
Doucet, E ;
Hamon, M ;
Menziani, MC ;
De Benedetti, PG ;
Bruni, G ;
Romeo, MR ;
Giorgi, G ;
Donati, A .
JOURNAL OF MEDICINAL CHEMISTRY, 1999, 42 (09) :1556-1575
[9]  
Case D.A., 2006, AMBER, P9
[10]  
CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099